fluoromisonidazole has been researched along with apatinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, L; Chu, X; Guo, T; Jiang, S; Li, Y; Ni, J; Yang, X; Zhou, Y; Zhu, Z; Zou, L | 1 |
1 other study(ies) available for fluoromisonidazole and apatinib
| Article | Year |
|---|---|
Low- dose Apatinib promotes vascular normalization and hypoxia reduction and sensitizes radiotherapy in lung cancer.
Topics: Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Female; Humans; Hypoxia; Lung Neoplasms; Mice; Mice, Inbred C57BL; Radiation-Sensitizing Agents; Tumor Microenvironment | 2023 |